622 related articles for article (PubMed ID: 32276137)
1. Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic.
Gasmi A; Noor S; Tippairote T; Dadar M; Menzel A; Bjørklund G
Clin Immunol; 2020 Jun; 215():108409. PubMed ID: 32276137
[TBL] [Abstract][Full Text] [Related]
2. COVID-19: Transmission, prevention, and potential therapeutic opportunities.
Lotfi M; Hamblin MR; Rezaei N
Clin Chim Acta; 2020 Sep; 508():254-266. PubMed ID: 32474009
[TBL] [Abstract][Full Text] [Related]
3. The Wuhan SARS-CoV-2-What's next for China.
Lu H; Stratton CW; Tang YW
J Med Virol; 2020 Jun; 92(6):546-547. PubMed ID: 32115732
[No Abstract] [Full Text] [Related]
4. COVID-19: Main therapeutic options.
Hachfi W; Ben Lasfar N
Tunis Med; 2020 Apr; 98(4):299-303. PubMed ID: 32395792
[No Abstract] [Full Text] [Related]
5. Where are we with understanding of COVID-19?
Akula SM; McCubrey JA
Adv Biol Regul; 2020 Aug; 77():100745. PubMed ID: 32773101
[TBL] [Abstract][Full Text] [Related]
6. World War against COVID-19: How strong is our armamentarium?
Ramachandran V; Marimuthu RR; Chinnambedu RS
Med J Malaysia; 2020 May; 75(3):314-315. PubMed ID: 32467555
[TBL] [Abstract][Full Text] [Related]
7. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.
Wang Y; Wang Y; Chen Y; Qin Q
J Med Virol; 2020 Jun; 92(6):568-576. PubMed ID: 32134116
[TBL] [Abstract][Full Text] [Related]
8. Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.
Liya G; Yuguang W; Jian L; Huaiping Y; Xue H; Jianwei H; Jiaju M; Youran L; Chen M; Yiqing J
APMIS; 2020 Jun; 128(6):423-432. PubMed ID: 32363707
[TBL] [Abstract][Full Text] [Related]
9. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
Patil AM; Göthert JR; Khairnar V
Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
[TBL] [Abstract][Full Text] [Related]
10. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
Wooding DJ; Bach H
Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
[TBL] [Abstract][Full Text] [Related]
11. Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
Gupta SP
Curr Top Med Chem; 2020; 20(26):2362-2378. PubMed ID: 32962613
[TBL] [Abstract][Full Text] [Related]
12. Prioritizing clinical research studies during the COVID-19 pandemic: lessons from New York City.
Gulick RM; Sobieszczyk ME; Landry DW; Hollenberg AN
J Clin Invest; 2020 Sep; 130(9):4522-4524. PubMed ID: 32692726
[No Abstract] [Full Text] [Related]
13. Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?
Xi Y
Signal Transduct Target Ther; 2020 Sep; 5(1):203. PubMed ID: 32934211
[No Abstract] [Full Text] [Related]
14. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence.
Wang L; Wang Y; Ye D; Liu Q
Int J Antimicrob Agents; 2020 Jun; 55(6):105948. PubMed ID: 32201353
[TBL] [Abstract][Full Text] [Related]
15. How likely are COVID-19 interventions to benefit the sickest patients?
Perner A; Tirupakuzhi Vijayaraghavan BK; Venkatesh B
Intensive Care Med; 2020 Jul; 46(7):1441-1444. PubMed ID: 32519004
[No Abstract] [Full Text] [Related]
16. Why do COVID death rates seem to be falling?
Ledford H
Nature; 2020 Nov; 587(7833):190-192. PubMed ID: 33177662
[No Abstract] [Full Text] [Related]
17. Audio Interview: Approaches to Covid-19 Vaccines and Antivirals.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Apr; 382(16):e58. PubMed ID: 32320592
[No Abstract] [Full Text] [Related]
18. Plasma-derived therapy: can the survivors of COVID-19 help the defenseless?
Majbour N; El-Agnaf O
Diagnosis (Berl); 2020 Nov; 7(4):373-376. PubMed ID: 32692700
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for caring for patients with severe and nonsevere COVID-19.
Paladugu S; Donato AA
Ann Intern Med; 2020 Jul; 173(2):JC3. PubMed ID: 32687760
[TBL] [Abstract][Full Text] [Related]
20. COVID-19: the novel coronavirus disease and its manifestations and management in ophthalmology.
Sun S; Su W; Lin CQ; Li X; Yan H; Tian B; Lin H
Discov Med; 2020; 29(158):145-157. PubMed ID: 33007190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
